Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders

The anticonvulsant topiramate not only decreases ethanol consumption in alcohol dependence (AD) but also may produce several adverse events including cognitive impairment. Zonisamide is a structurally related anticonvulsant that is a promising agent for the treatment of AD and may have greater toler...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Psychopharmacol
Autores principales: Knapp, Clifford M., Ciraulo, Domenic A., Sarid-Segal, Ofra, Richardson, Mark A., Devine, Eric, Streeter, Chris C., Oscar-Berman, Marlene, Surprise, Caitlin, Colaneri, Laurie, Putnam, Meghan, Waters, Megan, Richambault, Courtney
Formato: Artigo
Lenguaje:Inglês
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Contributions
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4276485/
https://ncbi.nlm.nih.gov/pubmed/25427171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000246
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares